CN104758451A - Traditional Chinese medicine composite for treating gout - Google Patents
Traditional Chinese medicine composite for treating gout Download PDFInfo
- Publication number
- CN104758451A CN104758451A CN201510209743.4A CN201510209743A CN104758451A CN 104758451 A CN104758451 A CN 104758451A CN 201510209743 A CN201510209743 A CN 201510209743A CN 104758451 A CN104758451 A CN 104758451A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- gout
- treatment
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composite for treating gout. According to the technical scheme, the traditional Chinese medicine composite for treating gout includes echinacea extract, harpagophytum procumbens extract, celery seeds, mustard seeds, fresh ginger extract, turmeric, pueraria flavones, folium ginkgo, sarsaparillae radix, cayenne pepper, plantain herb and other plant extractives and Chinese herbal medicine. The traditional Chinese medicine composite for treating gout is combined with traditional Chinese medicine syndrome differentiation, is matched scientifically, and can suppress synthesis of purine, neutralize acidic material in the blood and effectively suppress hyperuricemia through mutual cooperation function. In addition, the traditional Chinese medicine composite for treating gout can reduce blood fat, promote homergy in the body and boost immunity, has the functions of adjusting immunity and reducing uric acid and has no side and toxic effect.
Description
Technical field
The invention belongs to Chinese medicine composition field, relating to a kind of is particularly main component with plant extract, for the Chinese medicine composition of gout.
Background technology
Gout refers to that in human body, the metabolism of purine substance gets muddled, the synthesis of uric acid increases or discharges and reduces, and causes hyperuricemia, when serum Uric Acid Concentration is too high, uric acid is deposited in joint, cartilage and kidney with the form of sodium salt, causes and organizes foreign body inflammatory reaction.Gout is distributed in all over the world, by race, diet, drink, the multifactor impact such as professional, environment and schooling.The prevalence of European and American areas gout is 0.2% ~ 1.7%.In China, the sickness rate of gout is also in rising trend in recent years.Gout is first of hundred pains, once the thorough heart of outbreak pain, hotch, diseased joints is cannot moved, and therefore, gout has a strong impact on daily life and work.After suffering from gout, as treated not in time, the lighter causes joint to have an intense pain, and kidney damage and hypertension can appear in serious words, angina pectoris, a series of disease such as diabetes.The medicine of existing treatment gout is mainly Western medicine, and Western medicine is mainly chemosynthesis material, has certain toxic and side effects.
Summary of the invention
In order to overcome the above problems, the invention provides a kind of toxic and side effects little, Be very effective, the Chinese medicine composition of the treatment gout of combining with plant extract and Chinese herbal medicine.
The technical solution used in the present invention is: a kind of Chinese medicine composition for the treatment of gout, comprises following raw material medicaments in part by weight proportioning and makes: Echinacea extract 40-60 part, devil claw root extract 40-60 part, celery seed 80-120 part, chilly 10-30 part.
Above-mentioned a kind of Chinese medicine composition for the treatment of gout, by weight, containing 40-60 part Semen Brassicae Junceae.
Above-mentioned a kind of Chinese medicine composition for the treatment of gout, by weight, containing 40-60 part Rhizoma Zingiberis Recens extract.
Above-mentioned a kind of Chinese medicine composition for the treatment of gout, by weight, containing 20-40 part Rhizoma Curcumae Longae.
Above-mentioned a kind of Chinese medicine composition for the treatment of gout, by weight, containing 20-40 part Radix Puerariae flavone.
Above-mentioned a kind of Chinese medicine composition for the treatment of gout, by weight, containing 20-40 part Folium Ginkgo.
Above-mentioned a kind of Chinese medicine composition for the treatment of gout, by weight, containing 20-40 part Asparagus curillus root.
Above-mentioned a kind of Chinese medicine composition for the treatment of gout, by weight, containing 60-80 part Herba Plantaginis.
Above-mentioned a kind of Chinese medicine composition for the treatment of gout, makes oral formulations by compositions, and described oral formulations is tablet, capsule or electuary.
The invention has the beneficial effects as follows: the present invention for primary raw material, discusses therapy in conjunction with Chinese medical discrimination, scientific compatibility with plant extracts such as Echinacea extract and devil claw root extracts, mutual synergism, the synthesis of purine can be suppressed, in and blood in acidic materials, effectively suppress metabolic arthritis; Reduce blood fat, promote homergy in body, enhancing immunity, has immunity moderation power, the effect of uric acid resisting, and has no side effect.
Detailed description of the invention
Embodiment 1 one kinds treats the Chinese medicine composition of gout
Comprise following raw material medicaments in part by weight proportioning to make:
Echinacea extract 40mg, devil claw root extract 40mg, celery seed 120mg, chilly 30mg.
By above-mentioned crude drug, mix homogeneously, grinding, makes oral granule.Above-mentioned dosage is taking dose once a bag, morning and evening every day twice, each one bag.
By adopting 4 taste Chinese medicine synergism, effective to the therapeutic effect of initial stage gout, effective percentage is 80.2%.
Embodiment 2 one kinds treats the Chinese medicine composition of gout
Comprise following raw material medicaments in part by weight proportioning to make:
Echinacea extract 60mg, devil claw root extract 40mg, celery seed 80mg, chilly 10mg, Semen Brassicae Junceae 50mg.
By above-mentioned crude drug, mix homogeneously, grinding, makes capsule.Above-mentioned dosage is the dosage of a capsules, morning and evening every day twice, each one.
By adopting 5 taste Chinese medicine synergism, effective to the therapeutic effect of initial stage gout, effective percentage is 84.5%.
Embodiment 3 one kinds treats the Chinese medicine composition of gout
Comprise following raw material medicaments in part by weight proportioning to make:
Echinacea extract 60mg, devil claw root extract 40mg, celery seed 80mg, chilly 20mg, Semen Brassicae Junceae 50mg, Rhizoma Zingiberis Recens extract 50mg.
By above-mentioned crude drug, mix homogeneously, grinding, makes tablet.Above-mentioned dosage is the dosage of a slice, morning and evening every day twice, each a slice.
By adopting 6 taste Chinese medicine synergism, effective to the therapeutic effect of gout, effective percentage is 85.5%.
Embodiment 4 one kinds treats the Chinese medicine composition of gout
Comprise following raw material medicaments in part by weight proportioning to make:
Echinacea extract 50mg, devil claw root extract 50mg, celery seed 100mg, chilly 20mg, Semen Brassicae Junceae 50mg, Rhizoma Zingiberis Recens extract 50mg, Rhizoma Curcumae Longae 30mg.
By above-mentioned crude drug, mix homogeneously, grinding, makes tablet.Above-mentioned dosage is the dosage of a slice, morning and evening every day twice, each a slice.
By adopting 7 taste Chinese medicine synergism, effective to the therapeutic effect of gout, effective percentage is 86.4%.
Embodiment 5 one kinds treats the Chinese medicine composition of gout
Comprise following raw material medicaments in part by weight proportioning to make:
Echinacea extract 50mg, devil claw root extract 50mg, celery seed 90mg, chilly 10mg, Semen Brassicae Junceae 50mg, Rhizoma Zingiberis Recens extract 50mg, Rhizoma Curcumae Longae 30mg, Radix Puerariae flavone 30mg.
By above-mentioned crude drug, mix homogeneously, grinding, makes tablet.Above-mentioned dosage is the dosage of a slice, morning and evening every day twice, each a slice.
By adopting 8 taste Chinese medicine synergism, effective to the therapeutic effect of gout, effective percentage is 88.4%.
Embodiment 6 one kinds treats the Chinese medicine composition of gout
Comprise following raw material medicaments in part by weight proportioning to make:
Echinacea extract 60mg, devil claw root extract 40mg, celery seed 80mg, chilly 20mg, Semen Brassicae Junceae 50mg, Rhizoma Zingiberis Recens extract 50mg, Rhizoma Curcumae Longae 30mg, Radix Puerariae flavone 30mg, Folium Ginkgo 30mg.
By above-mentioned crude drug, mix homogeneously, grinding, makes tablet.Above-mentioned dosage is the dosage of a slice, morning and evening every day twice, each a slice.
By adopting 9 taste Chinese medicine synergism, effective to the therapeutic effect of gout, effective percentage is 89.5%.
Embodiment 7 one kinds treats the Chinese medicine composition of gout
Comprise following raw material medicaments in part by weight proportioning to make:
Echinacea extract 60mg, devil claw root extract 40mg, celery seed 80mg, chilly 20mg, Semen Brassicae Junceae 50mg, Rhizoma Zingiberis Recens extract 50mg, Rhizoma Curcumae Longae 30mg, Radix Puerariae flavone 30mg, Folium Ginkgo 30mg, Asparagus curillus root 30mg.
By above-mentioned crude drug, mix homogeneously, grinding, makes tablet.Above-mentioned dosage is the dosage of a slice, morning and evening every day twice, each a slice.
By adopting 10 taste Chinese medicine synergism, effective to the therapeutic effect of gout, effective percentage is 90.5%.
Embodiment 8 one kinds treats the Chinese medicine composition of gout
(1) formula
Comprise following raw material medicaments in part by weight proportioning to make:
Echinacea extract 50mg, devil claw root extract 50mg, celery seed 100mg, chilly 20mg, Semen Brassicae Junceae 50mg, Rhizoma Zingiberis Recens extract 50mg, Rhizoma Curcumae Longae 30mg, Radix Puerariae flavone 30mg, Folium Ginkgo 30mg, Asparagus curillus root 30mg, Herba Plantaginis 70mg.
(2) by above-mentioned crude drug, mix homogeneously, grinding, makes a tablet.Above-mentioned dosage is the dosage of a slice.
(3) therapeutic effect
1, physical data
Patient 160 example, wherein male 91 example, women 69 example.
2, diagnostic criteria:
Arthralgia, patient at night shows effect, and pain, is difficult to fall asleep;
Hyperuricemia: blood uric acid increases, male more than 0.38-mmol/L; More than women 0.3lnenol/L.
3, Therapeutic Method
Every day takes a slice sooner or later, within 30 days, is a course for the treatment of, takes two courses for the treatment of continuously.
4, efficacy assessment standard
Cure: transference cure, lab testing Level of Serum Uric Acid is normal.
Take a turn for the better: arthroncus is disappeared, pain relief, and lab testing Level of Serum Uric Acid makes moderate progress.
Invalid: symptom and lab testing Level of Serum Uric Acid unchanged.
5, therapeutic outcome is in table 1
Table 1
| Number of cases | Cure | Take a turn for the better | Invalid |
| After two courses for the treatment of | 73 examples | 76 examples | 11 examples |
| 45.6％ | 47.5％ | 6.9％ |
The present invention adopts 11 taste Chinese medicine synergism, and remarkable to the therapeutic effect of gout, effective percentage is 93.1%.
Claims (10)
1. treat a Chinese medicine composition for gout, it is characterized in that: comprise following raw material medicaments in part by weight proportioning and make: Echinacea extract 40-60 part, devil claw root extract 40-60 part, celery seed 80-120 part, chilly 10-30 part.
2. a kind of Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: by weight, containing 40-60 part Semen Brassicae Junceae.
3. a kind of Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: by weight, containing 40-60 part Rhizoma Zingiberis Recens extract.
4. a kind of Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: by weight, containing 20-40 part Rhizoma Curcumae Longae.
5. a kind of Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: by weight, containing 20-40 part Radix Puerariae flavone.
6. a kind of Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: by weight, containing 20-40 part Folium Ginkgo.
7. a kind of Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: by weight, containing 20-40 part Asparagus curillus root.
8. a kind of Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: by weight, containing 60-80 part Herba Plantaginis.
9. a kind of Chinese medicine composition for the treatment of gout according to claim 1, is characterized in that: compositions is made oral formulations.
10. a kind of Chinese medicine composition for the treatment of gout according to claim 9, is characterized in that: described oral formulations is tablet, capsule or electuary.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510209743.4A CN104758451A (en) | 2015-04-28 | 2015-04-28 | Traditional Chinese medicine composite for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510209743.4A CN104758451A (en) | 2015-04-28 | 2015-04-28 | Traditional Chinese medicine composite for treating gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104758451A true CN104758451A (en) | 2015-07-08 |
Family
ID=53640774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510209743.4A Pending CN104758451A (en) | 2015-04-28 | 2015-04-28 | Traditional Chinese medicine composite for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104758451A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITUB20161030A1 (en) * | 2016-02-24 | 2017-08-24 | Indena Spa | USEFUL COMPOSITIONS IN PREVENTION AND / OR IN THE TREATMENT OF INFLAMMATION AND PAIN |
| CN109718308A (en) * | 2019-03-06 | 2019-05-07 | 青岛东海药业有限公司 | A kind of pueraria lobata celery seed composite preparation and its application |
| CN110170031A (en) * | 2019-05-28 | 2019-08-27 | 沈阳抗风竤生物技术有限公司 | For dissolving the food therapeutic composition of tophus |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102106583A (en) * | 2011-01-27 | 2011-06-29 | 秦永高 | Drink and heal-care product for reducing uric acid and using method |
| WO2012050162A1 (en) * | 2010-10-15 | 2012-04-19 | 株式会社資生堂 | Cellular life span extending agent, and telomerase activator |
-
2015
- 2015-04-28 CN CN201510209743.4A patent/CN104758451A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012050162A1 (en) * | 2010-10-15 | 2012-04-19 | 株式会社資生堂 | Cellular life span extending agent, and telomerase activator |
| CN102106583A (en) * | 2011-01-27 | 2011-06-29 | 秦永高 | Drink and heal-care product for reducing uric acid and using method |
Non-Patent Citations (5)
| Title |
|---|
| 「电5DD枺」: "紫锥菊提取物", 《HTTPS://BAIKE.BAIDU.COM/HISTORY/%E7%B4%AB%E9%94%A5%E8%》 * |
| 奥瑟夫等: "《家庭医疗保健处方百科》", 31 March 2002, 九州出版社 * |
| 孟琦: "尿酸高和痛风的营养素调理问题", 《HTTPS://BBS.IHERB.COM/THREAD-44281-1-20.HTML》 * |
| 徐明: "《家有妙方》", 31 August 2010, 福建科学技术出版社 * |
| 程虹毓等: "银杏叶提取物降尿酸及对黄嘌呤氧化酶抑制作用研究", 《中医药通报》 * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITUB20161030A1 (en) * | 2016-02-24 | 2017-08-24 | Indena Spa | USEFUL COMPOSITIONS IN PREVENTION AND / OR IN THE TREATMENT OF INFLAMMATION AND PAIN |
| WO2017144411A1 (en) * | 2016-02-24 | 2017-08-31 | Indena S.P.A. | Compositions useful in the prevention and/or treatment of inflammation and pain |
| CN108697751A (en) * | 2016-02-24 | 2018-10-23 | 因德纳有限公司 | Composition for prevention and or treatment inflammation and pain |
| IL261240A (en) * | 2016-02-24 | 2018-10-31 | Indena Spa | Compositions useful in the prevention and/or treatment of inflammation and pain |
| JP2019506421A (en) * | 2016-02-24 | 2019-03-07 | インデナ エッセ ピ ア | Compositions useful in the prevention and / or treatment of inflammation and pain |
| RU2752320C2 (en) * | 2016-02-24 | 2021-07-26 | Индена С.П.А. | Compositions useful in the prevention and/or treatment of inflammation and pain |
| CN108697751B (en) * | 2016-02-24 | 2022-01-21 | 因德纳有限公司 | Composition for preventing and/or treating inflammation and pain |
| JP7111617B2 (en) | 2016-02-24 | 2022-08-02 | インデナ エッセ ピ ア | Compositions Useful in Preventing and/or Treating Inflammation and Pain |
| US11534472B2 (en) | 2016-02-24 | 2022-12-27 | Indena S.P.A. | Compositions useful in the prevention and/or treatment of inflammation and pain |
| AU2017222166B2 (en) * | 2016-02-24 | 2023-11-09 | Indena S.P.A. | Compositions useful in the prevention and/or treatment of inflammation and pain |
| CN109718308A (en) * | 2019-03-06 | 2019-05-07 | 青岛东海药业有限公司 | A kind of pueraria lobata celery seed composite preparation and its application |
| CN110170031A (en) * | 2019-05-28 | 2019-08-27 | 沈阳抗风竤生物技术有限公司 | For dissolving the food therapeutic composition of tophus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105395577B (en) | A kind of anti-trioxypurine composition and its preparation | |
| CN104758451A (en) | Traditional Chinese medicine composite for treating gout | |
| CN102240353A (en) | Traditional Chinese drug anesthetic and preparation method thereof | |
| CN1160108C (en) | Medicine for treating cholecystitis and its preparing process | |
| CN107412684A (en) | A kind of stone frog tadpole inflammation medication and its preparation technology | |
| CN103861007B (en) | A kind of Chinese herbal compound preparation for the treatment of chicken diarrhea | |
| CN103211946B (en) | Traditional Chinese medicine for treating gastric ulcer and duodenal ulcer | |
| CN104645081A (en) | Traditional Chinese medicine capsules for treating trigeminal neuralgia and preparation method thereof | |
| WO2019142042A1 (en) | Synergistic medicinal preparation for treating skin disorders like tinea versicolor | |
| CN103585330B (en) | A kind of Chinese medicine composition for cutaneous fungal infection and preparation method thereof | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN109316540A (en) | A kind of strengthening the spleen and stomach acupoint plaster and preparation method thereof | |
| CN102698056A (en) | Medicine for treating tinea pedis and preparation method thereof | |
| CN102357147A (en) | Chinese medicine composite tincture capable of diminishing inflammation, relieving pain and preventing viruses and preparation method thereof | |
| CN1879721A (en) | A compound capsule for treating Bi syndrome | |
| CN105832946A (en) | Medicine for treating human cancer and production method thereof | |
| CN106474420A (en) | The Chinese medicine composition of a kind of prevention or treating cancer, preparation and its application | |
| CN109303325A (en) | A kind of prevention or the traditional Chinese medicinal ointment taste for treating dry syndrome and preparation method thereof | |
| RU2571287C1 (en) | Agent for endoecological rehabilitation | |
| CN104208597A (en) | Chinese medicinal formula for treating kidney stone | |
| CN103816358A (en) | Traditional Chinese medicinal composition for clearing lung and eliminating phlegm | |
| CN107648354A (en) | A kind of Chinese medicine composition for treating treaitng Yin-deficiency constipation | |
| CN101406501A (en) | Medicine for treating rheumatic diseases | |
| CN107929628A (en) | A kind of medicine for treating rheumatic arthritis | |
| CN102178820A (en) | Medicament for treating sore throat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150708 |